openPR Logo
Press release

Global Epilepsy Drugs Market is expected US$ 9 Billion by 2025

01-15-2019 10:12 AM CET | Health & Medicine

Press release from: Renub Research

epilepsy-drugs-market-forecast

epilepsy-drugs-market-forecast

Access full Research:
https://www.renub.com/epilepsy-drugs-market-p.php

Get Free Customization in This Report

Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$ 9 Billion landmark by 2025.

Epilepsy can develop in both males and females of all races, ethnic backgrounds and ages. It affects around 65 Million people globally. United States has around 3.4 Million epilepsy patients; among them around 470 Thousands are children. Epilepsy prevalence varies across various parts of the world. At present, nearly one-third of the total patients are suffering from uncontrollable seizures and are not able to get treatment because no available treatment works for them.

Request a free sample copy of the report: https://www.renub.com/contactus.php

The factors that are driving the global Epilepsy drug market are increasing epilepsy prevalence, growing patient awareness programs, government funding and drugs reimbursement options in European & American countries. Recently, anti-epilepsy drugs Epidiolex approvals for pediatric epilepsies, namely Lennox-Gastaut syndrome and Dravet syndrome in United States will also help in the growth of Epilepsy drug market during the forecast period as well.

Renub Research report titled “Epilepsy Drugs Market by Country (United States, United Kingdom, France, Germany, Italy, Spain, India, China, Japan), Drugs [(Vimpat (Lacosamide), Keppra (Levetiracetam), Sabril (Vigabatrin), Onfi (Clobazam), Fycompa, Briviact (Brivaracetam), Epidiolex, Cenobamate (YKP3089)], Treatment Drugs Generation (First, Second, Third), Company (Eisai Co., Ltd, UCB Inc., H. Lundbeck A/S, GW Pharmaceuticals Plc.) & Forecast” provides a complete analysis of Global Epilepsy Drugs Market. This report also covers all-encompassing analysis of the key growth drivers and challenges, market trends, key players and their projections for the future.

By Country – United States is Dominating Global Epilepsy Drugs Market
The report studies the market of the following countries: United States, United Kingdom, France, Germany, Italy, Spain, India, China and Japan. United States is dominating global epilepsy drugs market. Its share is expected to grow in the years to come due to better healthcare support system, growing awareness and increasing per capita healthcare expenditure.

By Drugs – Vimpat (Lacosamide), Keppra (Levetiracetam) and Epidiolex are playing a significant role
The report studies the market of the following drugs: Vimpat (Lacosamide), Keppra (Levetiracetam), Sabril (Vigabatrin), Onfi (Clobazam), Fycompa, Briviact (Brivaracetam), Epidiolex, Cenobamate (YKP3089). At present, Vimpat (Lacosamide) and Keppra (Levetiracetam) are playing the significant role for the epilepsy treatment. Epidiolex has a bright future ahead.

By Drugs Category – Second and Third Generation Plays the Significant Role
In this report, we have categorized the epilepsy drugs market into three generation; First Generation, Second Generation, Third Generation. It is anticipated that second and third generation plays the significant role in the global epilepsy drugs market during the forecast period of 2019-2025.

Company Analysis
Eisai Co., Ltd, UCB Inc., H. Lundbeck A/S and GW Pharmaceuticals Plc. are some of the top companies that deal efficiently in epilepsy business globally. These companies have been studied thoroughly in the report.

Countries covered in this report are:
• United States
• United Kingdom
• France
• Germany
• Italy
• Spain
• India
• China
• Japan

Epilepsy Drugs Category – By Generation
• First Generation
• Second Generation
• Third Generation

Drugs covered in this report are:
• Vimpat (Lacosamide)
• Keppra (Levetiracetam)
• Sabril (Vigabatrin)
• Onfi (Clobazam)
• Fycompa
• Briviact (Brivaracetam)
• Epidiolex
• Cenobamate (YKP3089)

Companies covered in this report are:
• Eisai Co., Ltd
• UCB Inc.
• H. Lundbeck A/S
• GW Pharmaceuticals Plc.

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com

Contact Us
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.

225 Kristie Ln, Roswell, GA 30076, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Epilepsy Drugs Market is expected US$ 9 Billion by 2025 here

News-ID: 1497123 • Views:

More Releases from Renub Research

Lung Cancer Diagnostics Market, Size, Global Forecast, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis
Lung Cancer Diagnostics Market, Size, Global Forecast, Industry Trends, Share, G …
Global lung cancer diagnostics market is projected to attain about US$ 30.84 billion through 2030, as per Renub Research Lung cancers consequences from uncontrolled cell growth, forming loads referred to as tumors. Typically originating from the lining cells of the airlines (bronchi and bronchioles), it is frequently referred to as bronchogenic cancers or carcinoma. Cigarette smoking is the primary cause, contributing to approximately 90% of instances, at the same time
Industrial Enzymes Market Surges Towards US$ 10.10 Billion by 2030, Indicates Market Analysis ⅼ Forecast 2024 - 2030
Industrial Enzymes Market Surges Towards US$ 10.10 Billion by 2030, Indicates Ma …
Global Industrial Enzymes Market size is projected to be priced at around US$ 10.10 billion by 2030, according to Renub Research. Enzymes are proteins that catalyze chemical reactions. As such, enzymes have been widely used to facilitate industrial processes and the production of products, and these enzymes are referred to as industrial enzymes. Although it dates back to ancient times when enzymes were used in baking, brewing, cheese making, etc.,
Global Cosmetics Market: Explosive Growth Anticipated with 532% CAGR Forecast from 2024 to 2032, Reveals Latest Market Research Report ⅼ Renub Research
Global Cosmetics Market: Explosive Growth Anticipated with 532% CAGR Forecast fr …
Renub Research predicts the cosmetics market will reach US$ 498.05 Billion by 2032. The cosmetics enterprise has grown to be an important a part of human beings' daily lifestyles, and social media advertising has end up a widespread strategy for diverse organizations within the market to growth buyer attain. The rise in internet penetration and social media customers presents a possibility for cosmetics organizations to promote their services and products
Autoimmune Disease Diagnostics Market Hits US$5.32 Billion in 2023, Anticipated to Surge at 7.17% CAGR from 2024 to 2030 ⅼ Renub Research
Autoimmune Disease Diagnostics Market Hits US$5.32 Billion in 2023, Anticipated …
Global Autoimmune Disease Diagnostics market is projected to be valued at around US$ 8.64 Billion by 2030, as per Renub Research. Autoimmune disease diagnostics normally contain a combination of blood markers, specific signs, and sometimes a tissue biopsy. Autoimmune disorders broaden whilst the immune device attacks its cells due to abnormalities. The failure to detect immune cells, tissues, & organs and produce autoantibodies targeting these cells reasons the immune system

All 5 Releases


More Releases for United

Movable Walls Market By Top Key Players- Hufcor (United States), Dormakaba (Swit …
Global Movable Walls Market Report from Advance Market Analytics (AMA) covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market. The market characteristics section of the report defines and explains the market. The market size section gives the electronic equipment market revenues, covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external
Military Personal Protective Equipment Market 2024 | 3M Ceradyne (United States) …
Military personal protective equipment has become a crucial and standard element of soldier equipment. One of the major factor driving the market is the increasing role of ground troops in different parts of the world such as Iraq, Afghanistan and India among others. The demand for military personal protective equipment is anticipated to be driven by modernization initiatives undertaken by several large defense spenders globally and various internal security threats,
Infrared Sensor Market 2024 | Honeywell International, Inc. (United States), Tex …
Infrared sensors are devices emitting, detecting, receiving infrared waves as heat and infrared radiation. However, there are only a few among these sensors which are capable of only receiving the waves. Most of the infrared detectors are coated with either Fresnel lenses or parabolic mirrors for receiving infrared waves from an entire area. As these waves reach the sensor, it generates a voltage in different waves that is used for
Internet of Things Market 2021 | Google Inc. (United States), Cisco Systems Inc. …
The Internet of Things refers to the network of physical objects that attribute an IP address for Internet connectivity. Internet of Things is defined as an invisible and intelligent network of things that communicate indirectly or directly with each other. Internets of Things enable communication between the physical objects and other internet-enabled systems and devices. In addition, Internet of Things also makes the life of consumers much more comfortable and
Logistics Market | Global Growing Industry Key Players - J.B. Hunt Transport Ser …
Market Research Reports Search Engine (MRRSE) has recently updated its massive research catalog by adding a new study, titled “Logistics Market”. The study offers a clear insight about the prevailing trends and innovations happening in the Logistics Market. Readers can further access details about research highlights and executive summary to gain a better idea about this assessment. The market overview covers key industry developments and market opportunity map during the
Global Logistics Market 2024 | Key Players : J.B. Hunt Transport Services (Unite …
A fresh report has been added to the wide database of Market Research Report Search Engine (MRRSE). The research study is titled “Logistics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. Request for a sample of this research report @ https://www.mrrse.com/sample/2184 Logistics is